Zalcberg J R, Healey K, Hurrell J G, McKenzie I F
Int J Immunopharmacol. 1983;5(5):397-402. doi: 10.1016/0192-0561(83)90014-0.
A number of monoclonal antibodies to digoxin, two of which have been further characterized, were produced by somatic cell fusion. No cross reactivity with chemically related drugs was detected. Preliminary in vivo studies showed altered digoxin pharmacokinetics in antibody treated mice. These monoclonal antibodies could be used for a standardized radioimmunoassay and in the treatment of digoxin toxicity.
通过体细胞融合制备了多种抗地高辛单克隆抗体,其中两种已得到进一步鉴定。未检测到与化学相关药物的交叉反应性。初步的体内研究表明,抗体处理的小鼠体内地高辛的药代动力学发生了改变。这些单克隆抗体可用于标准化放射免疫分析以及地高辛中毒的治疗。